Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $254.8K | $0 | $0 |
| Gross margin | — | — | — | — |
| R&D | $0 | $0 | $7.1M | $10.4M |
| Operating income | −$332.0K | −$2.9K | −$16.2M | −$18.5M |
| EBITDA | −$332.0K | $0 | $1.1M | $1.1M |
| Net income | −$315.5K | −$667.7K | −$11.1M | −$95.5M |
| Net margin | — | — | — | — |
| EPS (diluted) | -0.00 | -0.01 | -0.22 | -22.58 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds PBAX.
No tracked institution reports a position in PBAX as of their last filing.
No one on the platform has traded PBAX yet.
| -3.97% |
| $20M |
| — |
| GDNRGardiner Healthcare Acquisitions Corp. | $10.90 | +0.65% | $41M | — |
| IROHIron Horse Acquisitions Corp. Common Stock | $4.09 | +0.00% | $36M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.